Calumet, Inc. (CLMT) 股票分析

公司概述

Calumet, Inc. operates as a comprehensive provider within the specialty chemicals sector, manufacturing, formulating, and marketing a diverse slate of specialty branded products alongside renewable fuels across North American and international markets. The company organizes its operations into three distinct segments: Specialty Products and Solutions, Performance Brands, and Montana/Renewables, reflecting a diversified approach to serving industrial and consumer needs. This enterprise is categorized under the Basic Materials sector and the Specialty Chemicals industry, positioning it as a key supplier of essential chemical inputs and alternative fuel solutions. In terms of scale, the company holds a market capitalization of $2.90B and generates annual revenue of $4.14B, employing a workforce of 1540 individuals to support its global operations. These financial figures indicate that Calumet, Inc. maintains a significant presence in the specialty chemical landscape, with revenue levels that suggest substantial operational breadth and a market valuation that reflects investor expectations for its diversified product portfolio and renewable energy initiatives.

财务健康

The company reported trailing twelve-month revenue of $4.14B with a corresponding net income of -$33,800,000 and an EBITDA of $227.30M. The substantial gap between the robust revenue figure of $4.14B and the negative net income of -$33,800,000 reveals a cost structure where operating expenses and interest costs significantly erode pre-tax profits, resulting in a negative profit margin despite positive cash generation from operations. Free cash flow stands at -$74,237,504, which indicates that the company is currently consuming cash to fund its operations and capital expenditures, thereby limiting its immediate financial flexibility for significant debt repayment or large-scale acquisitions without external financing. Margin analysis shows a gross margin of 6.3%, an operating margin of -3.3%, and a profit margin of -0.8%, where the low gross margin suggests intense competition or high input costs, while the negative operating and profit margins highlight the pressure on the bottom line from fixed costs and interest obligations. On the balance sheet, the company holds $125.10M in cash against total debt of $2.46B, creating a scenario where liabilities vastly exceed liquid assets, and the debt-to-equity ratio is listed as N/A, suggesting a capital structure heavily weighted toward debt or complex equity arrangements that obscure traditional leverage metrics. The current ratio is 1.02, which indicates that the company's short-term assets are only marginally higher than its short-term liabilities, signaling a tight liquidity position that requires careful management of working capital. Return on Equity is listed as N/A due to the financial structure, while Return on Assets sits at 1.8%, revealing that management is generating a modest return on the asset base despite the current profitability challenges.

估值评估

The valuation metrics present a complex picture, with the P/E Ratio (TTM) listed as N/A due to negative earnings and a forward P/E of 98.38, which implies that the market is pricing in significant expected earnings growth to justify the current share price in the coming fiscal periods. The price-to-book ratio is -3.96, a negative figure that indicates the market is valuing the company at a substantial discount relative to its book value, often seen in distressed or turnaround situations where tangible assets do not fully reflect the enterprise's potential. Alternative valuation metrics such as the price-to-sales ratio of 0.70 and an EV/EBITDA of 24.12 suggest that the stock is trading at a premium relative to its sales and earnings power, reflecting high investor expectations for future operational improvements. The stock has experienced significant volatility over the past year, trading between a 52-week low of $7.68 and a 52-week high of $36.94, meaning the current price sits at a level that requires specific calculation relative to the high but is fundamentally defined by the wide trading range observed in the secondary market. The beta value of 0.85 indicates that the stock's price volatility is lower than the broader market, suggesting a slightly defensive characteristic relative to the overall equity market, although the negative earnings complicate the interpretation of risk in traditional terms.

Growth & Income

Revenue growth year-over-year is recorded at 9.4%, while earnings growth is listed as N/A due to the current negative net income position. This divergence implies that the company is successfully expanding its top line through volume or price increases, but the bottom line has not yet benefited proportionally, likely due to the high fixed costs and interest expenses previously noted. As a non-dividend payer, the company reports a dividend yield of N/A and a payout ratio of 0.0%, indicating that all available cash flow is being retained and reinvested into the business for growth rather than being distributed to shareholders. The overall growth and income profile is characterized by strong top-line expansion coupled with a lack of current income distribution, reflecting a strategy focused on operational restructuring and market share acquisition rather than immediate shareholder returns.